Dignitana AB (DIGN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Dignitana AB (DIGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010895
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dignitana AB (Dignitana), a subsidiary of Eurosund AB, designs, develops, and markets medical refrigeration systems. The company’s flagship product, DigniCap system offers uniform scalp cooling to reduce hair loss in patients undergoing chemotherapy. The DigniCap system consists of DigniCool refrigeration and control unit and a silicone cap connected to the cooling and control unit. DigniCool circulates through tunnels in the cap and is used to maintain the preferred temperature. Dignitana’s scalp cooling technology has patents in Europe, Japan, Korea, China, and the US. The company offers this product to hospitals, healthcare institutions, and medical centers. It operates a subsidiary in Texas, the US. Dignitana is headquartered in Lund, Scania, Sweden.

Dignitana AB (DIGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dignitana AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dignitana AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dignitana AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dignitana AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Dignitana AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Dignitana AB, Medical Equipment, Deal Details 10
Partnerships 10
Dignitana Enters into Agreement with Boa Technology 10
Dignitana Enters Into Distribution Agreement With Konica Minolta Medical 11
Equity Offering 12
Dignitana to Raise USD5 Million in Rights Offering of Shares 12
Dignitana to Raise up to USD4 Million in Private Placement of Shares 13
Dignitana to Raise up to USD2.4 Million in Rights Offering of Shares 14
Dignitana to Raise USD3.37 Million in Private Placement of Units 16
Dignitana to Raise USD2.3 Million in Rights Offering 17
Dignitana AB – Key Competitors 18
Dignitana AB – Key Employees 19
Dignitana AB – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 24, 2017: Dignitana publish interim financial report for Q2, 2017 21
May 24, 2017: Dignitana publish interim financial report for Q1, 2017 24
Feb 23, 2017: Dignitana publishes Year End Financial Report 2016 26
Nov 24, 2016: Dignitana publish interim financial report for Q3, 2016 28
Aug 25, 2016: Dignitana publish interim financial report for Q2 2016 30
Feb 24, 2016: Dignitana publishes Year End Financial Report 2015 31
Corporate Communications 33
Nov 08, 2016: Dignitana Names Top Tech Engineer Johan Ericsson As Chief Executive Officer And Expands U.S. Leadership Team 33
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Dignitana AB, Medical Equipment, Key Facts, 2016 2
Dignitana AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Dignitana AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Dignitana AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Dignitana AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Dignitana AB, Deals By Market, 2011 to YTD 2017 8
Dignitana AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Dignitana Enters into Agreement with Boa Technology 10
Dignitana Enters Into Distribution Agreement With Konica Minolta Medical 11
Dignitana to Raise USD5 Million in Rights Offering of Shares 12
Dignitana to Raise up to USD4 Million in Private Placement of Shares 13
Dignitana to Raise up to USD2.4 Million in Rights Offering of Shares 14
Dignitana to Raise USD3.37 Million in Private Placement of Units 16
Dignitana to Raise USD2.3 Million in Rights Offering 17
Dignitana AB, Key Competitors 18
Dignitana AB, Key Employees 19
Dignitana AB, Subsidiaries 20

★海外企業調査レポート[Dignitana AB (DIGN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dr. Paul Lohmann GmbH & Co KGaA:企業の戦略・SWOT・財務分析
    Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report Summary Dr. Paul Lohmann GmbH & Co KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ENGlobal Corp (ENG):石油・ガス:M&Aディール及び事業提携情報
    Summary ENGlobal Corp (ENGlobal) is a specialty engineering services firm that offers oilfield automation solutions. The firm’s services comprise automation integration, engineering and construction, subsea controls and integration, and automation engineering and design services. Its automation inte …
  • Lutron Electronics Co Inc:企業の戦略的SWOT分析
    Lutron Electronics Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Vygon SA:企業の戦略的SWOT分析
    Vygon SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Pioneer Energy Services Corp (PES):石油・ガス:M&Aディール及び事業提携情報
    Summary Pioneer Energy Services Corp (Pioneer) is an oilfield services company that provides land contract drilling and production services. It provides drilling rigs, crew and the ancillary equipment to operate rigs. Its production services include wireline, well servicing and coiled tubing. The co …
  • Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • MedMira Inc (MIR):企業の財務・戦略的SWOT分析
    Summary MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the …
  • Ocera Therapeutics Inc:企業のM&A・事業提携・投資動向
    Ocera Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ocera Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Canadian Tire Corporation, Limited:戦略・SWOT・企業財務分析
    Canadian Tire Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Canadian Tire Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Terma AS:企業の戦略・SWOT・財務情報
    Terma AS - Strategy, SWOT and Corporate Finance Report Summary Terma AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Jackson Electric Membership Corporation:企業の発電所・SWOT分析2018
    Jackson Electric Membership Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Telenor ASA:企業の戦略・SWOT・財務分析
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析
    Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Funtastic Ltd (FUN):企業の財務・戦略的SWOT分析
    Funtastic Ltd (FUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Bhansali Engineering Polymers Ltd (BEPL):企業の財務・戦略的SWOT分析
    Summary Bhansali Engineering Polymers Ltd (BEPL), formerly Bhansali Steel Ltd is a petrochemical company that manufactures and markets acrylonitrile butadiene styrene. The company's products include general ABS, extrusion ABS, flame retardant ABS, ABS-GF or SAN-GF, PMMA-ABS, PVC modifier, PC or ABS …
  • Akers Biosciences Inc (AKER):製薬・医療:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Achelios Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Achelios Therapeutics Inc (Achelios) is a biopharmaceutical development company that provides reformulation of non-steroidal anti-inflammatory (NSAID) drug molecules. The company offers therapeutic entity development for the treatment of pain and inflammation. Its lead product includes Topof …
  • Cegid Group SA:企業の戦略的SWOT分析
    Cegid Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • DiaGenic ASA (NEL)-医療機器分野:企業M&A・提携分析
    Summary DiaGenic ASA (DiaGenic) is a medical device company that develops innovative in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from th …
  • MIS Implants Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary MIS Implants Technologies Ltd (MIS) is a medical device company that offers advanced products and solutions for dental implantology treatment. The company offers dental implants, tools and kits, superstructures, and solutions for oral restoration and health, among others. Its implants compri …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆